This study is currently recruiting patients. Sponsored by LEO Pharma. The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol plus betamethasone dipropionate gel is more effective than twice daily treatment of calcipotriol scalp solution in patients with scalp psoriasis. The primary outcome is patients with clear or minimal disease after 8 weeks of treatment.
Study ID Numbers: MBL 0503 INT
ClinicalTrials.gov Identifier: NCT00243464
COPYRIGHT 2006 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2006 Gale Group